What is the share price of Amar Remedies Ltd (AMAR)?

Company share prices are keep on changing according to the market conditions. The current trading price of Amar Remedies Ltd (AMAR) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Amar Remedies?

The latest standalone P/E ratio of Amar Remedies as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Amar Remedies Ltd (AMAR)?

The latest standalone P/B ratio of Amar Remedies Ltd (AMAR) as of 01-Jan-1970 is 0.07.

What is the 52-week high and low of Amar Remedies Ltd (AMAR)?

The 52-week high of Amar Remedies Ltd (AMAR) is Rs. 6.34 and the 52-week low is Rs. 5.74.

Amar Remedies Ltd (AMAR) Share Analysis – Brand Strength, Quality & Valuation Zone & DeciZen Rating

Name: Amar Remedies Ltd (AMAR)
Brand: Amar Remedies

Amar Remedies Ltd (AMAR)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532664 NSE: AMAR Household & Personal Products | Small Cap | Amar Remedies Share Price

Amar Remedies Ltd (AMAR)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532664 NSE: AMAR Household & Personal Products | Small Cap | Amar Remedies Share Price

Key Metrics

Valuation Multiples

Market Cap

₹16 Cr.

Current Price

₹0

52-Week Low / High

₹6 / 6

TTM EPS

₹-16.2

TTM Sales

₹492 Cr.

Book Value per Share

₹83.2

P/E Ratio

0.00

Industry PE

44.9

Price to Book (P/B)

0.07

Price to Sales (P/S)

0.03

EV/EBITDA

10.59

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

19.22%

Return on Capital Employed (ROCE)

17.66%

Return on Assets (ROA)

7.71%

Operating Profit Margin

17.1%

Net Profit Margin

6.71%

Gross Profit Margin

11.1%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

16.67%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

37.17%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

18.9%

Asset Quality

Promoter Holding

24.60%

Pledged shares (%) of Promoter's holding (%)

99.66%

Reserves

₹191 Cr.

Equity

₹26.2 Cr.

Face Value

₹10

All Time Low / High

₹5.48 / 171.00

Amar Remedies stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Jun'03	Jun'04	Jun'05	Jun'06	Jun'07	Jun'08	Jun'09	Jun'10	Jun'11	Jun'12	TTM
ROCE % ⓘ	0%	16%	26.6%	35.4%	18.7%	20.2%	20.4%	21.9%	18.9%	17.7%	-
Growth Parameters ⓘ
Sales ⓘ	0	82.2	107	167	202	298	369	472	578	674	492
Sales YoY Gr.	-	NA	29.9%	56.5%	20.9%	47.6%	23.8%	28%	22.4%	16.7%	-
Adj EPS ⓘ	0	3.3	6.2	8	6.5	8.3	10.2	12.4	14.5	19.2	-16.2
YoY Gr.	-	NA	90.5%	29.4%	-18.7%	27.8%	22.6%	21.2%	17.3%	32.6%	-
BVPS (₹) ⓘ	0	16.2	22.4	31.9	38.6	47.1	56.3	67.6	81.2	98.7	83.2
Adj Net Profit ⓘ	0	3.6	6.9	21	17.1	21.8	26.7	32.3	37.9	50.3	-42
Cash Flow from Ops. ⓘ	0	0	-1.4	-9.1	15.4	2.3	2.9	-12.2	-0.1	-21.1	-
Debt/CF from Ops. ⓘ	0	0	-10.9	-3.2	3.5	24.3	30	-10.2	-1777.2	-18	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	27.3%	22.2%	16.7%
Adj EPS ⓘ	NA	24.2%	23.5%	32.6%
BVPSⓘ	NA	20.7%	20.6%	21.5%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Jun'04	Jun'05	Jun'06	Jun'07	Jun'08	Jun'09	Jun'10	Jun'11	Jun'12	TTM
Return on Equity % ⓘ	18	29.4	35.9	17.4	18.5	19	19.4	19.1	21.1	-17.8
Op. Profit Mgn % ⓘ	6.6	9.4	16.6	13.1	11.9	12.9	14.5	14.2	17.1	7.2
Net Profit Mgn % ⓘ	4.4	6.5	12.5	8.4	7.3	7.2	6.8	6.6	7.5	-8.6
Debt to Equity ⓘ	0.7	0.6	0.4	0.5	0.5	0.6	0.7	1.2	1.5	-
Working Cap Days ⓘ	0	117	125	154	131	147	161	182	228	63
Cash Conv. Cycle ⓘ	0	110	116	138	119	131	140	153	182	17

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Jun'04	Jun'05	Jun'06	Jun'07	Jun'08	Jun'09	Jun'10	Jun'11	Jun'12
Sales	82.21	106.78	167.14	202.07	298.22	369.16	472.40	578.01	674.37
Operating Expenses ⓘ +	76.78	96.83	139.42	175.70	262.82	321.64	404.22	495.72	561.49
Manufacturing Costs	1.80	2.01	3.76	4.21	4.10	92.20	119.48	6.58	7.26
Material Costs	70.32	89.88	124.27	155.55	245.56	214.45	264.11	456.69	509.72
Employee Cost	1.52	1.67	3.09	6.08	6.49	5.90	7.86	12.69	16.13
Other Costs ⓘ	3.13	3.27	8.31	9.86	6.68	9.10	12.77	19.76	28.38
Operating Profit ⓘ	5.43	9.95	27.72	26.38	35.40	47.52	68.19	82.29	112.88
Operating Profit Margin (%)	6.6%	9.3%	16.6%	13.1%	11.9%	12.9%	14.4%	14.2%	16.7%
Other Income ⓘ +	0.05	0.04	0.05	0.13	0.30	1.88	0.81	1.02	2.08
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	-5.03
Interest ⓘ	1.02	2.01	2.58	4.44	7.56	12.43	20.77	27.43	39.76
Depreciation ⓘ	0.51	0.53	0.74	1.51	2.07	7.12	10.29	11.04	12.82
Profit Before Tax ⓘ	3.95	7.46	24.45	20.56	26.07	29.85	37.93	44.84	57.35
Tax ⓘ	0.33	0.58	3.50	3.52	4.31	3.17	5.68	6.79	12.11
Profit After Tax	3.62	6.88	20.95	17.05	21.76	26.68	32.25	38.05	45.24
PAT Margin (%)	4.4%	6.4%	12.5%	8.4%	7.3%	7.2%	6.8%	6.6%	6.7%
Adjusted EPS (₹)	3.3	6.2	8.0	6.5	8.3	10.2	12.3	14.5	17.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	9.80%	8.10%	6.90%	0%

Valuation of Amar Remedies - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Jun'04	Jun'05	Jun'06	Jun'07	Jun'08	Jun'09	Jun'10	Jun'11	Jun'12
Equity and Liabilities
Shareholders Fund +	20.12	26.87	89.72	106.67	128.34	151.89	181.01	215.96	261.14
Share Capital ⓘ	11.16	11.16	26.16	26.16	26.16	26.16	26.16	26.16	26.16
Reserves ⓘ	8.95	15.71	63.55	80.50	102.18	125.72	154.84	189.79	234.98
Debt +	12.98	15.10	29.15	53.35	56.22	88.28	124.10	249.18	365.42
Long Term Debt	12.98	15.10	29.15	53.35	56.22	88.28	124.10	27.52	50.69
Short Term Debt	0	0	0	0	0	0	0	221.66	314.73
Minority Interest	0	0	0	0	0	0	0	0	0
Trade Payables	1.39	1.29	2.36	5.06	4.08	8.68	9.53	12.94	15.98
Others Liabilities ⓘ	2.71	0.39	8.20	18.55	24.68	39.09	47.69	12.12	40.32
Total Liabilities ⓘ	37.20	43.64	129.43	183.62	213.32	287.94	362.32	490.20	682.86
Fixed Assets
Net Fixed Assets ⓘ +	5.96	6.04	20.16	28.92	83.77	108.20	115.38	123.95	164.70
Gross Block	9.11	9.83	24.79	35.16	92.17	123.79	141.33	161	213.47
Accumulated Depreciation	3.14	3.79	4.63	6.24	8.39	15.59	25.95	37.05	48.77
CWIP ⓘ	0	0	21.80	52.43	0.25	0	0	11.29	0
Investments ⓘ	0	0	5.40	4.11	4.47	0.13	0.65	0.66	0.66
Inventories	11.04	18.77	34.02	39.90	48.97	80.27	113.80	152.08	233.04
Trade Receivables	19.27	18.24	39.26	48.03	67.98	82.32	108.02	139.40	184.34
Cash Equivalents	0.03	0.09	0.22	0.10	0.11	0.67	3.46	11.64	8.65
Others Assets ⓘ	0.89	0.49	8.57	10.11	7.77	16.35	21	51.18	91.48
Total Assets ⓘ	37.20	43.64	129.43	183.62	213.32	287.94	362.32	490.20	682.86

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Jun'05	Jun'06	Jun'07	Jun'08	Jun'09	Jun'10	Jun'11	Jun'12
Cash Flow From Operating Activity ⓘ +	-1.38	-9.11	15.40	2.31	2.94	-12.15	-0.14	-21.13
PBT ⓘ	7.34	24.34	20.47	25.99	29.77	37.86	44.84	62.39
Adjustment ⓘ	2.14	0.01	3.04	6.21	20.13	31.63	38.96	48.01
Changes in Working Capital ⓘ	-8.85	-30.89	-3.67	-22.33	-31.03	-55.37	-77.44	-120.53
Tax Paid ⓘ	0	0	0	0	-3.50	-5.50	-6.50	-11
Cash Flow From Investing Activity ⓘ +	-0.72	-42.19	-39.64	-5.18	-31.37	-17.82	-48.80	-58.35
Capex	-0.72	-36.76	-41	-4.83	-31.37	-17.54	0	7.78
Net Investments	0	0	0	0	0	0	-0	0
Others ⓘ	0	-5.43	1.36	-0.35	0	-0.28	-48.79	-66.13
Cash Flow From Financing Activity ⓘ +	2.12	51.40	24.20	2.87	29	32.76	57.12	76.48
Net Proceeds from Shares ⓘ	0	42	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	25.76	23.17
Interest Paid ⓘ	0	0	0	0	0	0	-27.43	-39.76
Dividend Paid ⓘ	0	0	0	0	-2.62	-2.62	-2.62	0
Others ⓘ	2.12	9.40	24.20	2.87	31.61	35.37	61.40	93.07
Net Cash Flow ⓘ	0.01	0.10	-0.04	0	0.56	2.79	8.18	-2.99

Financial Ratio

PARTICULARS	Jun'04	Jun'05	Jun'06	Jun'07	Jun'08	Jun'09	Jun'10	Jun'11	Jun'12
Ratios
ROE (%)	20	31.87	38.65	18.5	19.43	19.73	19.89	19.54	19.22
ROCE (%)	15.98	26.58	35.41	18.74	20.16	20.38	21.88	18.93	17.66
Asset Turnover Ratio	2.21	2.64	1.93	1.29	1.5	1.47	1.45	1.36	1.16
PAT to CFO Conversion(x)	-0.38	-1.32	0.74	0.14	0.14	-0.46	-0	-0.56	0
Working Capital Days
Receivable Days	85.60	64.10	62.80	78.80	71	74.30	73.50	77.70	87
Inventory Days	49	50.90	57.60	66.80	54.40	63.90	75	83.50	103.50
Payable Days	7.20	5.40	5.40	8.70	6.80	10.90	12.60	9	10.40

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

78.00

88.49

88.74

91.19

95.74

99.59

98.98

99.67

99.66

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Amar Remedies Ltd FAQs

The current trading price of Amar Remedies on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Amar Remedies stood at ₹15.88 Cr

The latest P/E ratio of Amar Remedies as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Amar Remedies as of 31-Dec-1969 is 0.07.

The 52-week high of Amar Remedies is ₹6.34 and the 52-week low is ₹5.74.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amar Remedies is ₹492 ( Cr.) .

Data is not available for this company.

No data found

About Amar Remedies Ltd

Amar Remedies, incorporated 1984, is engaged in the business of manufacturing a range of FMCG products. The company was incorporated as Swami Aushadalaya to foray into ayurvedic medicinal research and development. Later in 1995 the name of the company was changed to Amar Remedies.

The company established its first manufacturing facility in Surat, Gujarat. At that time when major toothpaste brands used gelatine as an ingredient, making their toothpastes non-vegetarian. Amar became first to launch a breakthrough product, which was a gelatine-free formula. In 1991, the company launched a â€˜Vegetarianâ€™ toothpaste in Gujarat.

Much later in 1998 the company widened its product portfolio and introduced Amar Strong, Amar Regular and Amar White Toothpaste.

In 2001, the company commenced a new manufacturing facility at Daman. This led to increase in capacity of manufacturing facility and developing more varieties of toothpaste.

Today ARL manufactures 25 ayurvedic and herbal products for local and export markets. Amar's products are exported to over 20 countries like USA, Canada, Italy, France, UK, Nigeria, Ghana, Sudan, Tanzania, Dubai and Panama, among others.

Headquartered in Mumbai, the companyâ€™s manufacturing facilities are located at Daman, Dehradun and Surat.

The company has a product portfolio that includes toothpastes, toothbrushes, petroleum jelly, talc, soaps, shampoo, lotions and creams. The company markets its products under brand name â€˜Amarâ€™.

The company has received ISO 9001:2000 certification for its quality management. The company has also received International Gold Star for Quality Award at the International Star Quality Convention held at Paris in 2007. The company is recognised as â€˜One Star Export Houseâ€™ by Government of India and ministry of commerce and industry.

Future Strategy

Amar Remedies plans to invest Rs 25 crore to open 9 exclusive outlets of its newly-launched brand â€˜The Natureâ€™s Coâ€™ in the next 18 months. The company is intending to open these outlets in metros as well as Tier I and II cities including Mumbai, Bangalore, Hyderabad, Pune, Surat and Chandigarh.

Amar Remedies Ltd (AMAR)

Amar Remedies Ltd (AMAR)

Amar Remedies stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Amar Remedies - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Amar Remedies Ltd FAQs

About Amar Remedies Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Amar Remedies Ltd (AMAR)

Amar Remedies Ltd (AMAR)

Amar Remedies stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Amar Remedies - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Amar Remedies Ltd FAQs

What is the share price of Amar Remedies?

What is the market cap of Amar Remedies?

What is the P/E ratio of Amar Remedies?

What is the P/B ratio of Amar Remedies?

What is the 52-week high and low of Amar Remedies?

What is the TTM revenue of Amar Remedies?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Amar Remedies Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.